DE602005022994D1 - Assays für amphetamin und methamphetamin - Google Patents

Assays für amphetamin und methamphetamin

Info

Publication number
DE602005022994D1
DE602005022994D1 DE602005022994T DE602005022994T DE602005022994D1 DE 602005022994 D1 DE602005022994 D1 DE 602005022994D1 DE 602005022994 T DE602005022994 T DE 602005022994T DE 602005022994 T DE602005022994 T DE 602005022994T DE 602005022994 D1 DE602005022994 D1 DE 602005022994D1
Authority
DE
Germany
Prior art keywords
amphetamine
methamphetamine
linking group
moiety
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005022994T
Other languages
English (en)
Inventor
Yi Feng Zheng
Hshiou-Ting Liu
Richard F Parrish
Johnny Valdez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Publication of DE602005022994D1 publication Critical patent/DE602005022994D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602005022994T 2004-03-22 2005-03-16 Assays für amphetamin und methamphetamin Active DE602005022994D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/806,327 US7115383B2 (en) 2004-03-22 2004-03-22 Assays for amphetamine and methamphetamine
PCT/US2005/008679 WO2005092831A1 (en) 2004-03-22 2005-03-16 Assays for amphetamine and methamphetamine

Publications (1)

Publication Number Publication Date
DE602005022994D1 true DE602005022994D1 (de) 2010-09-30

Family

ID=34986839

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005022994T Active DE602005022994D1 (de) 2004-03-22 2005-03-16 Assays für amphetamin und methamphetamin

Country Status (6)

Country Link
US (1) US7115383B2 (de)
EP (1) EP1732880B1 (de)
AT (1) ATE478039T1 (de)
DE (1) DE602005022994D1 (de)
ES (1) ES2350637T3 (de)
WO (1) WO2005092831A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8614346B2 (en) 2009-06-19 2013-12-24 Cambrex Charles City, Inc. Methods and compositions for preparation of amphetamine conjugates and salts thereof
JP5094832B2 (ja) * 2009-12-25 2012-12-12 日東電工株式会社 粘着剤組成物および粘着シート
US8779191B2 (en) 2010-12-20 2014-07-15 Cambrex Charles City, Inc. Methods and compositions for preparing lisdexamfetamine and salts thereof
ES2911268T3 (es) 2013-12-17 2022-05-18 Siemens Healthcare Diagnostics Inc Preparación de conjugados de G6PDH mutante de múltiples haptenos y su uso para la detección de múltiples analitos

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US175995A (en) * 1876-04-11 Improvement in tire-upsetters
US170917A (en) * 1875-12-07 Improvement in ratchet-wheels
US1921424A (en) * 1930-03-08 1933-08-08 Smith Kline French Lab Medicinal remedy
US1879003A (en) * 1930-09-02 1932-09-27 Gordon A Alles Salts of 1-phenyl-2-aminopropane
US2344356A (en) * 1937-01-02 1944-03-14 Bilhuber Inc E Chemical compounds beta-(meta-hydroxyphenol)-isopropylamines
GB828880A (en) 1957-07-15 1960-02-24 Smith Kline French Lab 2-amino-1-(3, 4-methylenedioxyphenyl)-propane isomers and an ataractic preparation containing 2-amino-1-(3, 4-methylenedioxyphenyl)-propane
US3117160A (en) * 1961-07-27 1964-01-07 Pfizer & Co C Aralkylamines
DE1643310A1 (de) * 1966-12-29 1971-06-03 Dow Chemical Co 4-Alkyl-2,5-dimethoxy-alpha-methyl-phenaethylamin und seine pharmakologisch vertraeglichen Salze
SE348725B (de) * 1968-04-01 1972-09-11 Haessle Ab
CH543479A (de) 1970-05-06 1973-10-31 Hoffmann La Roche Verfahren zur Herstellung von Phenyläthylaminderivaten
US4097586A (en) * 1970-06-11 1978-06-27 Biological Developments, Inc. Immunochemical assay method
US3709868A (en) * 1971-03-08 1973-01-09 Hoffmann La Roche Opium alkaloid antigens and antibodies specific therefor
US5677132A (en) * 1971-05-20 1997-10-14 Strahilevitz; Meir Immunological assay reagent package
US3766162A (en) * 1971-08-24 1973-10-16 Hoffmann La Roche Barbituric acid antigens and antibodies specific therefor
DE2143204C3 (de) * 1971-08-28 1979-09-27 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt N-Fluoralkyl-phenylisopropylamin-Derivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel auf deren Basis
US3995021A (en) * 1972-05-15 1976-11-30 Biological Developments, Inc. Antigens of 5,5'alkylphenyl barbituric acids and related hydantoin compounds
US4022878A (en) * 1972-05-15 1977-05-10 Biological Developments, Inc. Methods and compounds for producing specific antibodies
US3996344A (en) * 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US4129598A (en) * 1972-05-31 1978-12-12 Synthelabo Phenylethylamine derivatives
US3847950A (en) * 1972-09-28 1974-11-12 Colgate Palmolive Co Alpha,alpha-dialkylphenethylamine derivatives
US3875011A (en) * 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
US3867366A (en) 1972-11-06 1975-02-18 Synvar Associates A K A Syva C Opiate imidates and protein conjugates thereof
US4058642A (en) * 1973-10-11 1977-11-15 Boehringer Ingelheim Gmbh 2-Amino-3-(3'-hydroxy-phenyl)-propanols and salts thereof
US4041076A (en) * 1974-10-23 1977-08-09 Hoffmann-La Roche Inc. Immunoassay for pharmacologically active phenethylamines
US4064228A (en) * 1974-11-29 1977-12-20 Biological Developments, Inc. Antigens and immunoassays for morphine and related 3-oxybenzomorphan compounds
US4016146A (en) * 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
US4036823A (en) * 1975-04-28 1977-07-19 Biological Developments, Inc. Barbituric acid antigenic conjugates, their preparation, antibodies and use
GB1467560A (en) 1975-11-27 1977-03-16 Nicholas Int Ltd Preparation of ethylamine derivatives
JPS5366417A (en) 1976-11-25 1978-06-13 Dainippon Pharmaceut Co Ltd Haptene antigens
US4218539A (en) * 1978-03-24 1980-08-19 Weltman Joel K Enzyme conjugates and method of preparation and use
US4329281A (en) * 1978-06-05 1982-05-11 Hoffmann-La Roche Inc. Hapten compositions
DE2844427A1 (de) 1978-10-12 1980-04-24 Heinrich Engelbert Dr Geissler 3-( beta -amino-aethyl)-phenole, deren herstellung und derartige verbindungen enthaltende praeparate
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
JPS56125666A (en) 1980-03-07 1981-10-02 Fujisawa Pharmaceut Co Ltd Immuno-analytical method for amphetamines and reagent thereof
US5198587A (en) * 1980-07-29 1993-03-30 Yamanouchi Pharmaceutical Co., Ltd. Phenethylamine derivatives
US4595656A (en) * 1984-01-06 1986-06-17 Becton Dickinson & Company Coupling agents and products produced therefrom
IT1199088B (it) * 1984-03-09 1988-12-30 Miles Italiana Saggio di legame specifico mediante impiego di anti-g6pdh come marcante
US4760142A (en) * 1984-11-27 1988-07-26 Hoechst Celanese Corporation Divalent hapten derivatives
DE3586314D1 (de) 1984-11-27 1992-08-13 Behringwerke Ag Bifunktionelle haptene, verfahren zu ihrer herstellung und ihre verwendung.
US4683136A (en) 1985-03-06 1987-07-28 Scripps Clinic And Research Foundation Proteinaceous antigens with conformation-independent and conformation-dependent determinants
DE3683953D1 (de) * 1985-05-31 1992-04-02 Syntex Inc Konjugate von glucose-6-phosphat-dehydrogenase, ihre herstellung und verwendung.
US4680338A (en) * 1985-10-17 1987-07-14 Immunomedics, Inc. Bifunctional linker
US5145791A (en) * 1986-07-09 1992-09-08 Abbott Laboratories 3-methoxy-4-hydroxyphenylglycol fluorescence polarization immunoassay
US4843147A (en) * 1986-11-06 1989-06-27 University Of British Columbia Anhydrous enhanced coupling of proteins
US4868132A (en) * 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
US4952336A (en) * 1987-02-03 1990-08-28 Abbott Laboratories Fluorescence polymerization immunoassay for amphetamine/methamphetamine
JPH0736929B2 (ja) 1987-03-09 1995-04-26 本田技研工業株式会社 金型移動穴抜き装置
DE58901057D1 (de) * 1988-01-25 1992-05-07 Boehringer Mannheim Gmbh Neue haptenderivate und davon abgeleitete hapten-protein-konjugate.
US5026827A (en) * 1988-09-02 1991-06-25 Matsushita Electric Industrial Co., Ltd. Amphetamine-protein complex as immunogen for obtaining antibodies specific to methamphetamine
US5233025A (en) * 1988-09-02 1993-08-03 Matsushita Electric Industrial Co., Ltd. Amphetamine protein complex as immunogen for obtaining antibodies specific to methamphetamine
JP2600325B2 (ja) 1988-09-02 1997-04-16 松下電器産業株式会社 抗体、抗体産生細胞および抗体の作製方法
US5262333A (en) * 1988-10-28 1993-11-16 Abbott Laboratories Method and reagents for detecting amphetamine and/or D-methamphetamine in biological samples
US5135863A (en) * 1988-12-23 1992-08-04 Syntex (U.S.A.) Inc. Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
GB8900666D0 (en) 1989-01-12 1989-03-08 Cancer Res Campaign Tech Derivatives of catecholamine metabolites,antibodies and labelled substances prepared therefrom,and immunoassays using the antibodies and labelled substances
JP2789208B2 (ja) * 1989-02-28 1998-08-20 株式会社第一ラジオアイソトープ研究所 Ｍｈｐｇに対する抗体の製造法
US5101015A (en) * 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
DE3919915A1 (de) 1989-06-19 1990-12-20 Boehringer Mannheim Gmbh Aminoalkylmaleimide und davon abgeleitete hapten- und antigenderivate sowie konjugate mit peptiden oder proteinen
GB9001694D0 (en) * 1990-01-25 1990-03-28 Therapeutic Antibodies Inc Immunogenic compositions
DE4040632A1 (de) * 1990-12-19 1992-06-25 Kali Chemie Pharma Gmbh Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69228682T2 (de) * 1991-04-10 1999-07-01 Biosite Diagnostics Inc "crosstalk"- oder übersprech-inhibitoren und ihre verwendung
EP0579767B1 (de) * 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Neue konjugate und testverfahren für die gleichzeitige bestimmung von multiplen liganden
US5284948A (en) 1991-06-07 1994-02-08 Eastman Kodak Company Drug hapten analogues for immunoassays
US5226720A (en) * 1992-01-08 1993-07-13 Ecolite Manufacturing Company, Inc. Louver adapter for "T" rail mounted light fixtures
EP0623214A1 (de) * 1992-01-17 1994-11-09 Selective Antibodies Limited Bestimmung von haptenen
US5518887A (en) * 1992-03-30 1996-05-21 Abbott Laboratories Immunoassays empolying generic anti-hapten antibodies and materials for use therein
US5270166A (en) * 1992-03-30 1993-12-14 Abbott Laboratories Immunoassays employing generic anti-hapten antibodies and materials for use therein
US5470997A (en) * 1992-04-06 1995-11-28 Biosite Diagnostics Incorporated Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
JPH07505634A (ja) * 1992-04-06 1995-06-22 バイオサイト・ダイアグノスティックス・インコーポレイテッド 新規オピエート誘導体，タンパクおよびポリペプチドオピエート誘導共役体および標識
CA2096495C (en) * 1992-06-16 2002-07-09 Kathy Palmer Ordonez Dual analyte immunoassay
DE4310142A1 (de) * 1993-03-29 1994-10-06 Boehringer Mannheim Gmbh Immunologisch aktive Konjugate und ein Verfahren zu ihrer Herstellung
US6455288B1 (en) * 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
JP3203108B2 (ja) * 1993-08-26 2001-08-27 協和メデックス株式会社 グルコース−６−リン酸デヒドロゲナーゼの安定化方法
US5492841A (en) * 1994-02-18 1996-02-20 E. I. Du Pont De Nemours And Company Quaternary ammonium immunogenic conjugates and immunoassay reagents
US5763218A (en) * 1996-05-20 1998-06-09 Human Genome Science, Inc. Nucleic acid encoding novel human G-protein coupled receptor
DE19630102A1 (de) * 1996-07-25 1998-01-29 Boehringer Mannheim Gmbh Neue aktivierte Amphetamine
AU4893897A (en) * 1997-05-27 1998-12-30 Microgenics Corporation Conjugates and specific immunoassays for the methadone metabolite 2-ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine
IL129322A (en) * 1997-08-07 2004-02-19 Fujimoto Brothers Co Ltd History of ethylamine and pharmaceutical preparations containing them
DE60228927D1 (de) 2001-12-20 2008-10-30 Randox Lab Ltd Verfahren und Kit zum Nachweis oder zur Bestimmung von 3,4-Methylendioxymethamphetamin
US7169907B2 (en) 2002-03-01 2007-01-30 Roche Diagnostics Operations, Inc. Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs
US20030170917A1 (en) 2002-03-01 2003-09-11 Roche Diagnostics Corporation Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes
US7022492B2 (en) * 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens

Also Published As

Publication number Publication date
ES2350637T3 (es) 2011-01-25
EP1732880A4 (de) 2008-05-14
EP1732880A1 (de) 2006-12-20
US7115383B2 (en) 2006-10-03
EP1732880B1 (de) 2010-08-18
US20050208604A1 (en) 2005-09-22
WO2005092831A1 (en) 2005-10-06
ATE478039T1 (de) 2010-09-15

Similar Documents

Publication Publication Date Title
BRPI0407397A (pt) Evento de algodão mon 88913 e composições e métodos para sua detecção
DE602005010579D1 (de) Nachweis von arzneistoffen der methamphetamingruppe
WO2007061793A3 (en) Modified cardiolipin and uses therefor
WO2008105896A3 (en) Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
WO2007100506A3 (en) Mass tags for quantitative analyses
ATE470857T1 (de) Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität
ATE495442T1 (de) Zusammensetzungen und verfahren zur erkennung von sirolimus
WO2009058902A3 (en) Methods and devices for analyte detection
EA201100231A1 (ru) Диагностический анализ на основе антител
ATE527383T1 (de) Multiplex-nukleinsäurenachweis
BRPI0607323B8 (pt) composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo
WO2006023312A3 (en) Diagnostic assay for source of inflammation
AR026735A1 (es) Inmunoensayo para insecticidas de neonicotinilo
BRPI0512081A (pt) azaporfirinas substituìdas como rótulos de fluorescência
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
WO2007035864A3 (en) Electrophoresis standards, methods and kits
AR067135A1 (es) Metodos para aislar arn de fragmento largo de muestras fijas
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma
WO2008103319A3 (en) Compounds and methods for use in detecting gabapentin
DE602005022994D1 (de) Assays für amphetamin und methamphetamin
FR2900936B1 (fr) Procede et methodes de detection de la maladie d'alzheimer
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
ATE553386T1 (de) Bluttypisierung
ATE467128T1 (de) Kolloidale metallkonjugate
WO2004010842A3 (en) Lipophilic electrophoretic probes